Management of Severe and Critical COVID-19 Infection with Immunotherapies.

Athale, Janhavi; Gallagher, Jolie; Busch, Lindsay M

Athale, Janhavi; Gallagher, Jolie; Busch, Lindsay M.

Afiliação

Athale J; Critical Care Medicine Department, Mayo Clinic, Phoenix, AZ, USA.
Gallagher J; Department of Pharmacy, Emory University Hospital, Atlanta, GA, USA.
Busch LM; Division of Infectious Diseases, Emory University School of Medicine, 101 Woodruff Memorial Building, Suite 2101, Atlanta, GA 30322, USA; Emory Critical Care Center, Atlanta, GA, USA. Electronic address: lindsay.margoles.busch@emory.edu.

Infect Dis Clin North Am ; 36(4): 761-775, 2022 12.

Article em En | MEDLINE | ID: mdl-36328635

Assuntos

COVID-19; Humanos; COVID-19/terapia; SARS-CoV-2; Estado Terminal/terapia; Pandemias; Respiração Artificial; Imunoterapia

Palavras-chave

Critical COVID-19 infection; Immunotherapy; Severe COVID-19 infection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Humans Idioma: En Revista: Infect Dis Clin North Am Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google